Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Nanoform Finland | NANOFS | 14. mai 2024 | 22.00 | +1.15 |
NeoDynamics | NEOD | 14. mai 2024 | 1.00 | 0.00 |
Neola Medical | NEOLA | 14. mai 2024 | 1.99 | +2.58 |
Newbury Pharmaceuticals | NEWBRY | 14. mai 2024 | 3.06 | -1.92 |
NGS Group | NGS | 14. mai 2024 | 3.54 | -0.28 |
Nosa Plugs | NOSA | 14. mai 2024 | 0.48 | -16.09 |
Odinwell | ODIN | 14. mai 2024 | 0.65 | -5.11 |
Ortivus A | ORTIA | 14. mai 2024 | 4.54 | -1.73 |
Ortivus B | ORTIB | 14. mai 2024 | 2.53 | -1.17 |
Ortoma B | ORTB | 14. mai 2024 | 8.44 | -2.09 |
Paxman | PAX | 14. mai 2024 | 40.30 | +0.75 |
Perpetua Medical B | PERPB | 14. mai 2024 | 0.09 | 0.00 |
PExA | PEXAB | 14. mai 2024 | 0.38 | +2.15 |
Pharmacolog i Uppsala B | PHLOGB | 14. mai 2024 | 0.10 | 0.00 |
Phase Holographic | PHI | 14. mai 2024 | 8.00 | -1.72 |
PMD Device Solutions | PMDS | 14. mai 2024 | 8.15 | -1.21 |
PolarCool | POLAR | 14. mai 2024 | 0.12 | +2.92 |
Prolight Diagnostics | PRLD | 14. mai 2024 | 0.14 | -3.45 |
ProstaLund | PLUN | 14. mai 2024 | 1.13 | -1.32 |
Prostatype Genomics | PROGEN | 14. mai 2024 | 0.04 | -13.73 |
Q-Linea | QLINEA | 14. mai 2024 | 2.31 | +0.87 |
Qlife Holding | QLIFE | 14. mai 2024 | 0.00 | +7.41 |
Redsense Medical | REDS | 14. mai 2024 | 6.24 | -2.50 |
S2Medical B | S2M | 14. mai 2024 | 0.05 | -2.14 |
ScandiDos | SDOS | 14. mai 2024 | 1.77 | +1.72 |
Scandinavian Real Heart | HEART | 14. mai 2024 | 0.41 | +2.01 |
Scibase Holding | SCIB | 14. mai 2024 | 0.28 | -4.83 |
Sectra B | SECTB | 14. mai 2024 | 239.40 | +2.05 |
Sedana Medical | SEDANA | 14. mai 2024 | 23.20 | +5.94 |
SensoDetect | SDET | 14. mai 2024 | 0.12 | -6.15 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.